Related Experiment Video
Updated: Jul 16, 2026
08:19
Assessing Mitochondrial Function in Sciatic Nerve by High-Resolution Respirometry
Published on: May 5, 2022
Brain mitochondrial dysfunction as a link between Alzheimer's disease and diabetes
Paula I Moreira1, Maria S Santos, Raquel Seiça
1Center for Neuroscience and Cell Biology, Institute of Physiology, Faculty of Medicine, University of Coimbra, 3004-354 Coimbra, Portugal.
Journal of the Neurological Sciences
|February 24, 2007
Summary
Impaired insulin signaling in Alzheimer's disease (AD) mirrors type 2 diabetes. Brain mitochondrial dysfunction, driven by oxidative stress, links these conditions and neurodegeneration.
Area of Science:
- Neuroscience
- Metabolic disorders
- Mitochondrial biology
Background:
- Late-onset Alzheimer's disease (AD) involves neuronal glucose metabolism disturbances, similar to type 2 diabetes.
- Mitochondria are central to reactive oxygen species (ROS) production and damage, implicated in AD and diabetes.
- The brain's high energy demand makes it vulnerable to mitochondrial dysfunction.
Purpose of the Study:
- To review brain mitochondrial dysfunction as a unifying link between Alzheimer's disease and diabetes.
- To explore the role of impaired insulin signaling and oxidative stress in neurodegeneration.
Main Methods:
- Literature review focusing on studies investigating mitochondrial function in AD and diabetes.
- Analysis of research on oxidative stress and its impact on brain mitochondria.
- Discussion of the shared pathophysiological mechanisms.
Main Results:
- Evidence suggests impaired insulin signaling in AD affects neuronal glucose metabolism.
- Mitochondrial damage and oxidative stress are common factors in both AD and diabetes.
- Dysfunction in the brain's mitochondrial electron transport chain impacts neuronal function and disease etiology.
Conclusions:
- Brain mitochondrial dysfunction is a key link connecting Alzheimer's disease and type 2 diabetes.
- Oxidative stress and impaired insulin signaling contribute to neurodegeneration in AD.
- Understanding these links may offer therapeutic targets for both conditions.
More Related Videos
08:48Using Live Cell STED Imaging to Visualize Mitochondrial Inner Membrane Ultrastructure in Neuronal Cell Models
Published on: June 30, 2023
09:40Phosphorus-31 Magnetic Resonance Spectroscopy: A Tool for Measuring In Vivo Mitochondrial Oxidative Phosphorylation Capacity in Human Skeletal Muscle
Published on: January 19, 2017
Related Concept Videos
01:29Alzheimer Disease l: Introduction
Alzheimer disease is a chronic, progressive, and irreversible neurodegenerative disorder and the most common cause of dementia in older adults. It leads to gradual neuronal loss, causing cognitive decline, behavioral changes, and loss of functional independence.Risk Factors and EtiologyThe disease is multifactorial. Age is the strongest risk factor, with prevalence doubling every 5 years after age 65. Genetic factors include mutations in genes such as APP, PSEN1, and PSEN2, which are associated...
01:26Alzheimer's Disease: Overview
Alzheimer's Disease (AD) is a continually advancing neurodegenerative disorder, distinguished by escalating memory loss, cognitive dysfunction, and dementia. The disease unfolds in three stages: preclinical, mild cognitive impairment (MCI), and dementia. Its onset is insidious, and the progression gradual, with the cause not well explained by other disorders.
The clinical diagnosis of AD hinges on the presence of memory and other cognitive impairments. Biomarkers, such as changes in Aβ and tau...
The clinical diagnosis of AD hinges on the presence of memory and other cognitive impairments. Biomarkers, such as changes in Aβ and tau...
01:37Mitochondria
Mitochondria are eukaryotic cellular organelles that are known to produce energy through a process called oxidative phosphorylation. Besides their primary function, mitochondria are involved in various cellular processes, including cell growth, differentiation, signaling, metabolism, and senescence. Age-related changes cause a decline in mitochondrial quality and integrity due to increased mitochondrial mutations and oxidative damage. Thus, aging can severely impact mitochondrial functions,...
01:23Alzheimer Disease ll: Pathophysiology
Alzheimer disease involves structural changes in the brain that begin long before symptoms appear. The most distinctive features are extracellular neuritic plaques and intracellular neurofibrillary tangles.Neuritic plaques form in the cerebral cortex and around blood vessels. These plaques contain a dense core of beta-amyloid (Aβ)—a toxic protein fragment that clumps outside neurons. The core is surrounded by damaged neuronal extensions, as well as reactive astrocytes and microglia. Abnormal...
01:24Parkinson Disease ll: Pathophysiology
Parkinson disease (PD) is a progressive neurodegenerative disorder primarily affecting movement, with additional non-motor features. Its pathophysiology involves complex interactions among genetic susceptibility, environmental exposures, and cellular dysfunction, including dopaminergic neuron loss, protein aggregation, and mitochondrial impairment.Selective NeurodegenerationA key feature is the degeneration of dopaminergic neurons in the substantia nigra pars compacta, leading to reduced...
01:22Dementia l: Introduction
Dementia is an acquired, progressive syndrome characterized by a decline in multiple cognitive domains severe enough to impair daily functioning and reduce independence. Although memory loss is a central feature, the diagnosis requires additional deficits involving language, executive function, visuospatial skills, judgment, calculation, or abstract reasoning. These cognitive impairments reflect underlying neurodegenerative or vascular processes that gradually disrupt neuronal networks...